Arcadia Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $31.1M | $28.7M |
| FY2022 | — | $21.0M | $20.6M |
| FY2023 | — | $12.8M | $6.5M |
| FY2024 | — | $6.2M | $4.2M |
| FY2025 | — | $4.1M | $259.0K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $31.1M | $28.7M |
| FY2022 | — | $21.0M | $20.6M |
| FY2023 | — | $12.8M | $6.5M |
| FY2024 | — | $6.2M | $4.2M |
| FY2025 | — | $4.1M | $259.0K |